» Authors » Andrea Aramini

Andrea Aramini

Explore the profile of Andrea Aramini including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 312
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Boccella S, Morace A, Giorgio C, Guida F, Perrone M, Manzo I, et al.
Diabetes Metab J . 2025 Mar; PMID: 40070263
Background: The CXC motif chemokine ligand 8 (CXCL8)-CXC motif chemokine receptor 1/2 (CXCR1/2) axis has been implicated in type 1 diabetes mellitus (T1DM). Its actions on non-immune cells may also...
2.
Greco R, Francavilla M, Facchetti S, Demartini C, Zanaboni A, Antonangeli M, et al.
J Headache Pain . 2024 Oct; 25(1):184. PMID: 39455939
Background: In addition to its critical role in neurogenesis, brain-derived neurotrophic factor (BDNF) modulates pain and depressive behaviors. Methods: In a translational perspective, we tested the anti-migraine activity of highly...
3.
Pisani A, Rolesi R, Mohamed-Hizam V, Montuoro R, Paludetti G, Giorgio C, et al.
Br J Pharmacol . 2024 Oct; 182(3):546-563. PMID: 39390645
Background And Purpose: Cisplatin-induced sensorineural hearing loss is a significant clinical challenge. Although the potential effects of brain-derived neurotrophic factor (BDNF) have previously been investigated in some ototoxicity models, its...
4.
Pozzer D, Indrigo M, Breccia M, Florio E, Franchino C, De Rocco G, et al.
Brain . 2024 Sep; 148(3):845-860. PMID: 39300821
MECP2 deficiency causes a broad spectrum of neuropsychiatric disorders that can affect both genders. Rett syndrome is the most common and is characterized by an apparently normal growth period followed...
5.
Lombardi M, Spartano L, Nicolo S, Ardita V, Chiesa R, Aramini A, et al.
Cardiovasc Res . 2024 Sep; 120(15):1832-1834. PMID: 39236224
No abstract available.
6.
Conte E, Mantuano P, Boccanegra B, Imbrici P, Dinoi G, Lenti R, et al.
Front Pharmacol . 2024 Jul; 15:1393746. PMID: 38962308
During aging, sarcopenia and decline in physiological processes lead to partial loss of muscle strength, atrophy, and increased fatigability. Muscle changes may be related to a reduced intake of essential...
7.
Boccella S, De Filippis L, Giorgio C, Brandolini L, Jones M, Novelli R, et al.
Biomolecules . 2023 Dec; 13(12). PMID: 38136672
Chronic neuropathic pain (NP) is an increasingly prevalent disease and leading cause of disability which is challenging to treat. Several distinct classes of drugs are currently used for the treatment...
8.
Castelli V, dAngelo M, Zazzeroni F, Vecchiotti D, Alesse E, Capece D, et al.
Cell Death Dis . 2023 Sep; 14(9):605. PMID: 37704645
Hearing loss impacts the quality of life and affects communication resulting in social isolation and reduced well-being. Despite its impact on society and economy, no therapies for age-related hearing loss...
9.
Grasselli C, Bombelli S, DEsposito V, Tolla M, LImperio V, Rocchio F, et al.
Diabetes Metab Res Rev . 2023 Jul; 39(7):e3694. PMID: 37470287
Aims: Diabetic nephropathy is a major consequence of inflammation developing in type 1 diabetes, with interleukin-8 (IL-8)-CXCR1/2 axis playing a key role in kidney disease progression. In this study, we...
10.
Aramini A, Bianchini G, Lillini S, Tomassetti M, Pacchiarotti N, Canestrari D, et al.
Biomed Pharmacother . 2023 May; 163:114845. PMID: 37167730
Chronic pain is an enormous public health concern, and its treatment is still an unmet medical need. Starting from data highlighting the promising effects of some nonsteroidal anti-inflammatory drugs in...